The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia
10.1186/1476-4598-11-72
Saved in:
Main Authors: | Zhou J., Cheong L.-L., Liu S.-C., Chong P.S.Y., Mahara S., Bi C., Ong K.O.K., Zeng Q., Chng W.J. |
---|---|
Other Authors: | DEPT OF MEDICINE |
Format: | Article |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143390 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Simvastatin enhances the efficacy of Bcr-Abl tyrosine kinase inhibitor nilotinib in chronic myeloid leukemia.
by: Koh, Yanqing.
Published: (2011) -
PRL-3 phosphatase and cancer metastasis
by: Al-Aidaroos, A.Q.O., et al.
Published: (2014) -
PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-aml therapy
by: Zhou, J., et al.
Published: (2014) -
Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia
by: Chong, Phyllis SY, et al.
Published: (2020) -
BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients
by: Wanwisa Wongboonma, et al.
Published: (2018)